GigaGen, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by GigaGen, Inc.
RECRUITINGPhase 1NCT06258304
A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor...
The purpose of this study is to assess the safety and tolerability of GIGA-564 and identify the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) level(s) of...
Sponsor: GigaGen, Inc.Enrolling: 601 location
Advanced or Metastatic Solid Tumor Malignancies
RECRUITINGPhase 1NCT07024641
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B...
The primary purpose of this study is to assess the safety and tolerability of single and multiple intravenous (IV) doses of GIGA-2339 in participants with chronic Hepatitis B...
Sponsor: GigaGen, Inc.Enrolling: 4816 locations
Hepatitis B Virus Infection